Testing effectiveness (Phase 2)Ended earlyNCT00066417
What this trial is testing
Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
National Heart, Lung, and Blood Institute (NHLBI) 51